Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum.

Patel V, Mazitschek R, Coleman B, Nguyen C, Urgaonkar S, Cortese J, Barker RH, Greenberg E, Tang W, Bradner JE, Schreiber SL, Duraisingh MT, Wirth DF, Clardy J.

J Med Chem. 2009 Apr 23;52(8):2185-7. doi: 10.1021/jm801654y.

2.

Targeting histone deacetylase inhibitors for anti-malarial therapy.

Andrews KT, Tran TN, Wheatley NC, Fairlie DP.

Curr Top Med Chem. 2009;9(3):292-308. Review.

PMID:
19355992
3.

Towards histone deacetylase inhibitors as new antimalarial drugs.

Andrews KT, Tran TN, Fairlie DP.

Curr Pharm Des. 2012;18(24):3467-79. Review.

PMID:
22607140
4.

Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.

Gardiner DL, Skinner-Adams TS, Brown CL, Andrews KT, Stack CM, McCarthy JS, Dalton JP, Trenholme KR.

Expert Rev Anti Infect Ther. 2009 Nov;7(9):1087-98. doi: 10.1586/eri.09.93. Review.

PMID:
19883329

Supplemental Content

Support Center